No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: IR response
10
Jan 11, 2022 02:21PM
3
Jan 11, 2022 03:03PM
5
Jan 11, 2022 03:41PM

Jan 11, 2022 03:44PM
2
Jan 12, 2022 12:42AM

IR's response just doesn't add up. Bear pretty much summarized why it doesn't on Dec 19, 2021, on this Hub.

fuzzyjr:    "Maybe Bear,CityC etc can shed some light on how long this sort of "screening" might take? I'm thinking a a few hours max , can't imagine it taking several day's given the immediate health issues/concern(s)??"


Bear: "I agree. It shouldn't take long to screen. I would guesstimate 1-3 days. It can't take too long, since one of the listed inclusion criteria is 10 days or less since onset of symptoms. Assuming that most patients will have experienced symptoms for a few days before being admitted to the hospital, this coud mean that screening must move fast once admitted to hospital. I expect a news release for start of dosing in first patient(s) this week, as early as tomorrow. However, my expectations have not matched reality several times with Resverlogix's clinical programs."

This can only mean that the 14 candidates they had in their midst for screening back the mid-December 2021 did not pan out seeing that no one has been dosed to date.

 

Koo

4
Jan 12, 2022 08:44AM
1
Jan 12, 2022 08:44AM

Jan 12, 2022 08:46AM
Share
New Message
Please login to post a reply